Polyclonal versus monoclonal immunoglobulin-free light chains quantification - Giuseppe Di Noto, Elena Cimpoies, Alessandra Dossi, Lucia Paolini, Annalisa Radeghieri, Luigi Caimi, Doris Ricotta, 2015
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Guide to Antibody structure and isotypes | Abcam
Frontiers | Understanding AL amyloidosis with a little help from in vivo models
Intrathecal kappa free light chains as markers for multiple sclerosis | Scientific Reports
Guide to Antibody structure and isotypes | Abcam
trend in serum free light chain levels and kappa-lambda free light... | Download Scientific Diagram
Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
APC Mouse anti-Human Ig, κ Light Chain
Immunoglobulin Kappa Chain - an overview | ScienceDirect Topics
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Immunoglobulin classes
Measuring M-Protein SPEP, UPEP Tests | Int'l Myeloma Fdn
Sebia FLC Kappa, Serum free light chain quantification
SARS-CoV-2 infection associated with monoclonal gammopathy. A case report based on the study of minimally invasive ultrasound-guided autopsy | Revista Española de Patología
JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
![Recombinant Anti-Kappa light chain antibody [EPR5367-8] (ab124727) | Abcam](https://www.abcam.com/ps/products/124/ab124727/Images/ab124727-8-anti-kappa-light-chain-antibody-epr5367-8-elisa.jpg "Recombinant Anti-Kappa light chain antibody [EPR5367-8] (ab124727) | Abcam")
Recombinant Anti-Kappa light chain antibody [EPR5367-8] (ab124727) | Abcam
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - 2023 - The FEBS Journal - Wiley Online Library
Validation of serum free light chain reference ranges in primary care - Luca Galvani, Jane Flanagan, Mansour Sargazi, William D Neithercut, 2016
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
